Table of Content

1 Market Overview of Nuclide Drugs
1.1 Nuclide Drugs Market Overview
1.1.1 Nuclide Drugs Product Scope
1.1.2 Nuclide Drugs Market Status and Outlook
1.2 Global Nuclide Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nuclide Drugs Market Size by Region (2018-2029)
1.4 Global Nuclide Drugs Historic Market Size by Region (2018-2024)
1.5 Global Nuclide Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nuclide Drugs Market Size (2018-2029)
1.6.1 North America Nuclide Drugs Market Size (2018-2029)
1.6.2 Europe Nuclide Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Nuclide Drugs Market Size (2018-2029)
1.6.4 Latin America Nuclide Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Nuclide Drugs Market Size (2018-2029)
2 Nuclide Drugs Market by Type
2.1 Introduction
2.1.1 Technetium-99
2.1.2 Iodine-123
2.1.3 Iodine-125
2.1.4 Iodine-131
2.1.5 Fluorine-18
2.1.6 Gallium-67
2.1.7 Others
2.2 Global Nuclide Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nuclide Drugs Historic Market Size by Type (2018-2024)
2.2.2 Global Nuclide Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nuclide Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nuclide Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nuclide Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nuclide Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nuclide Drugs Revenue Breakdown by Type (2018-2029)
3 Nuclide Drugs Market Overview by Application
3.1 Introduction
3.1.1 Therapeutic Use
3.1.2 Diagnostic Use
3.2 Global Nuclide Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nuclide Drugs Historic Market Size by Application (2018-2024)
3.2.2 Global Nuclide Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nuclide Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nuclide Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nuclide Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nuclide Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nuclide Drugs Revenue Breakdown by Application (2018-2029)
4 Nuclide Drugs Competition Analysis by Players
4.1 Global Nuclide Drugs Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
4.3 Date of Key Players Enter into Nuclide Drugs Market
4.4 Global Top Players Nuclide Drugs Headquarters and Area Served
4.5 Key Players Nuclide Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Nuclide Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Nuclide Drugs Products, Services and Solutions
5.1.4 GE Healthcare Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.1.5 GE Healthcare Recent Developments
5.2 Cardinal Health
5.2.1 Cardinal Health Profile
5.2.2 Cardinal Health Main Business
5.2.3 Cardinal Health Nuclide Drugs Products, Services and Solutions
5.2.4 Cardinal Health Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.2.5 Cardinal Health Recent Developments
5.3 Curium Pharma
5.3.1 Curium Pharma Profile
5.3.2 Curium Pharma Main Business
5.3.3 Curium Pharma Nuclide Drugs Products, Services and Solutions
5.3.4 Curium Pharma Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.3.5 Lantheus Medical Imaging, Inc. Recent Developments
5.4 Lantheus Medical Imaging, Inc.
5.4.1 Lantheus Medical Imaging, Inc. Profile
5.4.2 Lantheus Medical Imaging, Inc. Main Business
5.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Products, Services and Solutions
5.4.4 Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.4.5 Lantheus Medical Imaging, Inc. Recent Developments
5.5 Eczacıbaşı Monrol Nuclear Products
5.5.1 Eczacıbaşı Monrol Nuclear Products Profile
5.5.2 Eczacıbaşı Monrol Nuclear Products Main Business
5.5.3 Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Products, Services and Solutions
5.5.4 Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.5.5 Eczacıbaşı Monrol Nuclear Products Recent Developments
5.6 Novartis International AG
5.6.1 Novartis International AG Profile
5.6.2 Novartis International AG Main Business
5.6.3 Novartis International AG Nuclide Drugs Products, Services and Solutions
5.6.4 Novartis International AG Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis International AG Recent Developments
5.7 Siemens
5.7.1 Siemens Profile
5.7.2 Siemens Main Business
5.7.3 Siemens Nuclide Drugs Products, Services and Solutions
5.7.4 Siemens Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.7.5 Siemens Recent Developments
5.8 China Isotope & Radiation
5.8.1 China Isotope & Radiation Profile
5.8.2 China Isotope & Radiation Main Business
5.8.3 China Isotope & Radiation Nuclide Drugs Products, Services and Solutions
5.8.4 China Isotope & Radiation Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.8.5 China Isotope & Radiation Recent Developments
5.9 Yantai Dongcheng Pharmaceutical
5.9.1 Yantai Dongcheng Pharmaceutical Profile
5.9.2 Yantai Dongcheng Pharmaceutical Main Business
5.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Products, Services and Solutions
5.9.4 Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.9.5 Yantai Dongcheng Pharmaceutical Recent Developments
5.10 Jubilant Life Sciences
5.10.1 Jubilant Life Sciences Profile
5.10.2 Jubilant Life Sciences Main Business
5.10.3 Jubilant Life Sciences Nuclide Drugs Products, Services and Solutions
5.10.4 Jubilant Life Sciences Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.10.5 Jubilant Life Sciences Recent Developments
5.11 Bracco
5.11.1 Bracco Profile
5.11.2 Bracco Main Business
5.11.3 Bracco Nuclide Drugs Products, Services and Solutions
5.11.4 Bracco Nuclide Drugs Revenue (US$ Million) & (2018-2024)
5.11.5 Bracco Recent Developments
6 North America
6.1 North America Nuclide Drugs Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Nuclide Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nuclide Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nuclide Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nuclide Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nuclide Drugs Market Dynamics
11.1 Nuclide Drugs Industry Trends
11.2 Nuclide Drugs Market Drivers
11.3 Nuclide Drugs Market Challenges
11.4 Nuclide Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nuclide Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Nuclide Drugs Market Size Share by Region (2018-2024)
Table 4. Global Nuclide Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Nuclide Drugs Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Nuclide Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Nuclide Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Nuclide Drugs Revenue Market Share by Type (2018-2024)
Table 9. Global Nuclide Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Nuclide Drugs Revenue Market Share by Type (2024-2029)
Table 11. North America Nuclide Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Nuclide Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Nuclide Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Nuclide Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Nuclide Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Nuclide Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Nuclide Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Nuclide Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Nuclide Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Nuclide Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Nuclide Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Nuclide Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Nuclide Drugs Revenue Market Share by Application (2018-2024)
Table 24. Global Nuclide Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Nuclide Drugs Revenue Market Share by Application (2024-2029)
Table 26. North America Nuclide Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Nuclide Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Nuclide Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Nuclide Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Nuclide Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Nuclide Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Nuclide Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Nuclide Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Nuclide Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Nuclide Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Nuclide Drugs Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Nuclide Drugs Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclide Drugs as of 2022)
Table 39. Date of Key Players Enter into Nuclide Drugs Market
Table 40. Global Nuclide Drugs Key Players Headquarters and Area Served
Table 41. Nuclide Drugs Product Solution and Service
Table 42. Global Nuclide Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GE Healthcare Basic Information List
Table 45. GE Healthcare Description and Business Overview
Table 46. GE Healthcare Nuclide Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nuclide Drugs Business of GE Healthcare (2018-2024)
Table 48. GE Healthcare Recent Developments
Table 49. Cardinal Health Basic Information List
Table 50. Cardinal Health Description and Business Overview
Table 51. Cardinal Health Nuclide Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nuclide Drugs Business of Cardinal Health (2018-2024)
Table 53. Cardinal Health Recent Developments
Table 54. Curium Pharma Basic Information List
Table 55. Curium Pharma Description and Business Overview
Table 56. Curium Pharma Nuclide Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nuclide Drugs Business of Curium Pharma (2018-2024)
Table 58. Curium Pharma Recent Developments
Table 59. Lantheus Medical Imaging, Inc. Basic Information List
Table 60. Lantheus Medical Imaging, Inc. Description and Business Overview
Table 61. Lantheus Medical Imaging, Inc. Nuclide Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nuclide Drugs Business of Lantheus Medical Imaging, Inc. (2018-2024)
Table 63. Lantheus Medical Imaging, Inc. Recent Developments
Table 64. Eczacıbaşı Monrol Nuclear Products Basic Information List
Table 65. Eczacıbaşı Monrol Nuclear Products Description and Business Overview
Table 66. Eczacıbaşı Monrol Nuclear Products Nuclide Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Nuclide Drugs Business of Eczacıbaşı Monrol Nuclear Products (2018-2024)
Table 68. Eczacıbaşı Monrol Nuclear Products Recent Developments
Table 69. Novartis International AG Basic Information List
Table 70. Novartis International AG Description and Business Overview
Table 71. Novartis International AG Nuclide Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Nuclide Drugs Business of Novartis International AG (2018-2024)
Table 73. Novartis International AG Recent Developments
Table 74. Siemens Basic Information List
Table 75. Siemens Description and Business Overview
Table 76. Siemens Nuclide Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Nuclide Drugs Business of Siemens (2018-2024)
Table 78. Siemens Recent Developments
Table 79. China Isotope & Radiation Basic Information List
Table 80. China Isotope & Radiation Description and Business Overview
Table 81. China Isotope & Radiation Nuclide Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Nuclide Drugs Business of China Isotope & Radiation (2018-2024)
Table 83. China Isotope & Radiation Recent Developments
Table 84. Yantai Dongcheng Pharmaceutical Basic Information List
Table 85. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 86. Yantai Dongcheng Pharmaceutical Nuclide Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Nuclide Drugs Business of Yantai Dongcheng Pharmaceutical (2018-2024)
Table 88. Yantai Dongcheng Pharmaceutical Recent Developments
Table 89. Jubilant Life Sciences Basic Information List
Table 90. Jubilant Life Sciences Description and Business Overview
Table 91. Jubilant Life Sciences Nuclide Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Nuclide Drugs Business of Jubilant Life Sciences (2018-2024)
Table 93. Jubilant Life Sciences Recent Developments
Table 94. Bracco Basic Information List
Table 95. Bracco Description and Business Overview
Table 96. Bracco Nuclide Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Nuclide Drugs Business of Bracco (2018-2024)
Table 98. Bracco Recent Developments
Table 99. North America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 101. Europe Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 103. Asia-Pacific Nuclide Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Asia-Pacific Nuclide Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Nuclide Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 106. Asia-Pacific Nuclide Drugs Market Share by Region (2018-2024)
Table 107. Asia-Pacific Nuclide Drugs Market Share by Region (2024-2029)
Table 108. Latin America Nuclide Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 109. Latin America Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 111. Middle East & Africa Nuclide Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Middle East & Africa Nuclide Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Nuclide Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 114. Nuclide Drugs Market Trends
Table 115. Nuclide Drugs Market Drivers
Table 116. Nuclide Drugs Market Challenges
Table 117. Nuclide Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclide Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Nuclide Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Nuclide Drugs Market Share by Regions: 2022 VS 2029
Figure 4. Global Nuclide Drugs Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Nuclide Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Nuclide Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Nuclide Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Nuclide Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Nuclide Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Technetium-99
Figure 11. Global Technetium-99 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Iodine-123
Figure 13. Global Iodine-123 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Iodine-125
Figure 15. Global Iodine-125 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Iodine-131
Figure 17. Global Iodine-131 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Fluorine-18
Figure 19. Global Fluorine-18 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Product Picture of Gallium-67
Figure 21. Global Gallium-67 Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Product Picture of Others
Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Nuclide Drugs Market Size Share by Type: 2022 & 2029
Figure 25. North America Nuclide Drugs Revenue Market Share by Type (2018-2029)
Figure 26. Europe Nuclide Drugs Revenue Market Share by Type (2018-2029)
Figure 27. Asia-Pacific Nuclide Drugs Revenue Market Share by Type (2018-2029)
Figure 28. Latin America Nuclide Drugs Revenue Market Share by Type (2018-2029)
Figure 29. Middle East and Africa Nuclide Drugs Revenue Market Share by Type (2018-2029)
Figure 30. Therapeutic Use Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 31. Diagnostic Use Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 32. Global Nuclide Drugs Market Size Share by Application: 2022 & 2029
Figure 33. North America Nuclide Drugs Revenue Market Share by Application (2018-2029)
Figure 34. Europe Nuclide Drugs Revenue Market Share by Application (2018-2029)
Figure 35. Asia-Pacific Nuclide Drugs Revenue Market Share by Application (2018-2029)
Figure 36. Latin America Nuclide Drugs Revenue Market Share by Application (2018-2029)
Figure 37. Middle East and Africa Nuclide Drugs Revenue Market Share by Application (2018-2029)
Figure 38. Nuclide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 39. Global Top 5 and Top 10 Players Nuclide Drugs Market Share in 2022
Figure 40. North America Nuclide Drugs Market Share by Country (2018-2029)
Figure 41. United States Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 42. Canada Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 43. Germany Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 44. France Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 45. U.K. Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 46. Italy Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 47. Russia Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 48. Nordic Countries Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 49. Asia-Pacific Nuclide Drugs Market Share by Region (2018-2029)
Figure 50. China Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 51. Japan Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 52. South Korea Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 53. Southeast Asia Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 54. India Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 55. Australia Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 56. Latin America Nuclide Drugs Market Share by Country (2018-2029)
Figure 57. Mexico Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 58. Brazil Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 59. Middle East & Africa Nuclide Drugs Market Share by Country (2018-2029)
Figure 60. Turkey Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 61. Saudi Arabia Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 62. UAE Nuclide Drugs Market Size (2018-2029) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report